Publication Name	World Journal of Clinical Oncology
Manuscript ID	8522
Country	Switzerland

Received	2013-12-30 08:34
Peer-Review Started	2013-12-30 13:26
To Make the First Decision	2014-02-13 16:21
Return for Revision	2014-02-20 23:59
Revised	2014-02-28 21:06
Second Decision	2014-04-03 10:52
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2014-04-03 11:06
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-07-22 17:25
Publish the Manuscript Online	2014-08-01 16:16

ISSN	2218-4333 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Topic Highlights
Article Title	Brachytherapy in cancer cervix: Time to move ahead from point A?
Manuscript Source	Invited Manuscript
All Author List	Anurita Srivastava and Niloy Ranjan Datta
Funding Agency and Grant Number
Corresponding Author	Dr. Niloy Ranjan Datta, Professor, Centre for Radiation Oncology KSA-KSB, Kantonsspital Aarau, Tellstrasse 5, Aargau CH 5034, Switzerland. niloyranjan.datta@ksa.ch
Key Words	Cancer cervix; Intracavitary brachytherapy; Point A; Image guided brachytherapy; Computed tomography-guided brachytherapy; Magnetic resonance imaging-guided brachytherapy; Ultrasound guided brachytherapy
Core Tip	Traditionally, intracavitary brachytherapy in cancer cervix is based on dose prescription at point A. However, with the availability of computed tomography-magnetic resonance imaging compatible applicators, various imaging techniques, treatment planning systems for dose computations and evaluation, there is a gradual shift towards image based brachytherapy. The article reviews the evolution of dose prescription concepts from “point” to “image” based brachytherapy in the current clinical practice of intracavitary brachytherapy of cancer cervix. This could enable prescribing doses to conform the target and avoid normal structures based on individualized applicator geometry, tumour architecture and anatomy of the organs at risk, thereby improving the therapeutic outcome.
Publish Date	2014-08-01 16:16
Citation	Srivastava A, Datta NR. Brachytherapy in cancer cervix: Time to move ahead from point A? World J Clin Oncol 2014; 5(4): 764-774
URL	http://www.wjgnet.com/2218-4333/full/v5/i4/764.htm
DOI	http://dx.doi.org/10.5306/wjco.v5.i4.764

Full Article (PDF)	WJCO-5-764.pdf
Full Article (Word)	WJCO-5-764.doc
Manuscript File	8522-Review.doc
Answering Reviewers	8522-Answering reviewers.pdf
Copyright License Agreement	8522-Copyright assignment.pdf
Peer-review Report	8522-Peer review(s).pdf
Scientific Editor Work List	8522-Scientific editor work list.doc